{"jsonapi":{"version":"1.0"},"data":{"type":"recalls","id":"78fb685005a06260e466dfb752959a29c057280676eb96fbebf60e6ca2f800fe","attributes":{"feedName":"medwatch","feedSource":"medwatch","title":"Update on Risk of Type III Endoleaks with Use of Endologix AFX Endovascular AAA Graft Systems: FDA Safety Communication","description":"The FDA is evaluating new information about the risk of blood continuing to leak into the aneurysm (Type III endoleak) with Endologix AFX.","link":"http://www.fda.gov/medical-devices/safety-communications/update-risk-type-iii-endoleaks-use-endologix-afx-endovascular-aaa-graft-systems-fda-safety","publicationDate":"2019-10-28T04:00:00.000Z","state":"sent","affected":[],"allergens":[],"audience":["professionals"],"categories":["medical"],"contaminants":[],"distribution":["AK","AL","AR","AZ","CA","CO","CT","DC","DE","FL","GA","HI","IA","ID","IL","IN","KS","KY","LA","MA","MD","ME","MI","MN","MO","MS","MT","NC","ND","NE","NH","NJ","NM","NV","NY","OH","OK","OR","PA","RI","SC","SD","TN","TX","UT","VA","VT","WA","WI","WV","WY"],"risk":"none","token":"5db7254e2d8126009d379325"}}}